Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Astellas Pharma Inc
YPHCurrent price
11.36 EUR
0 EUR (0.00%)
Last closed
11.16 EUR
Company
www.astellas.com
ISIN
JP3942400007
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
Munich Exchange
Capitalization
19 958 639 905 EUR
Yield for 12 month
-17.74 %
1Y
3Y
5Y
10Y
15Y
YPH
Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally. The company provides XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for patients who have relapsed or refractory acute myeloid leukemia with a FLT3 mutation; and PADCEV, a treatment for patients with metastatic urothelial cancer. It also offers Evrenzo, a treatment for anemia associated with chronic kidney disease; Betanis/Myrabetriq/BETMIGA, a treatment for overactive bladder; and Prograf and Advagraf/Graceptor/ASTAGRAF XL immunosuppressants. Th company has a research collaboration with Vivtex Corporation to evaluate Vivtex's GI-ORIS screening and formulation platform technology to support the development of novel and oral versions of a therapeutic candidate provided by Astellas; and a partnership agreement with Roche Diabetes Care Japan Co., Ltd. to develop and commercialize integrated diabetes self-management solution. The company was founded in 1923 and is headquartered in Tokyo, Japan. Address: 2-5-1, Nihonbashi-Honcho, Tokyo, Japan, 103-8411
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
139.5Dividend Yield
3.81 %Current Year
+10 221 371 981 EUR
Last Year
+9 679 267 143 EUR
Current Quarter
+2 642 561 113 EUR
Last Quarter
+2 689 280 553 EUR
Current Year
+8 357 151 627 EUR
Last Year
+7 841 383 040 EUR
Current Quarter
+2 175 819 256 EUR
Last Quarter
+2 205 533 584 EUR
Key Figures YPH
1 year
3 years
5 years
10 years
EBITDA
279 761 968 859 EUR
Operating Margin TTM
PE Ratio
139.5
Return On Assets TTM
1.82 %
PEG Ratio
–
Return On Equity TTM
1.32 %
Wall Street Target Price
–
Revenue TTM
1 700 426 063 196 EUR
Book Value
935.48 EUR
Revenue Per Share TTM
Dividend Share
69.94 EUR
Quarterly Revenue Growth YOY
26.2 %
Dividend Yield
3.81 %
Gross Profit TTM
1 042 308 173 058 EUR
Earnings per share
0.08 EUR
Diluted Eps TTM
0.08 EUR
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
13.7 %
Profit Margin
1.26 %
Dividend Analytics YPH
Dividend growth over 5 years
76 %Continuous growth
9 yearsPayout Ratio 5 years average
195 %Dividend History YPH
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
0.45
Ex Dividend Date
27.09.2024
Forward Annual Dividend Yield
3.81 %
Last Split Factor
5:1
Payout Ratio
583.82 %
Last Split Date
27.03.2014
Dividend Date
–
Stock Valuation YPH
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
139.5
Forward PE
12.3457
Enterprise Value Revenue
2.2354
Price Sales TTM
0.0117
Enterprise Value EBITDA
16.7393
Price Book MRQ
2.072
Financials YPH
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators YPH
For 52 weeks
8.47 EUR
14.14 EUR
50 Day MA
10.03 EUR
Shares Short Prior Month
–
200 Day MA
9.81 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart